Jack Stewart discusses SOR-C18 potential in different cancers
Jack Stewart, CSO of Soricimed Biopharma elaborates on how SOR-C18 potentially showing promise in ovarian, metastatic prostate and pancreatic cancer.
Author: Cancer-News
Added: 08/23/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts